Prem Shankar Mishra | Computational Biology | Best Researcher Award

Published on by Molecular Biologist

Prof. Dr. Prem Shankar Mishra | Computational Biology | Best Researcher Award

Professor & Dean, at Faculty of Pharmacy, Vidya University, India.

Prof. Dr. Prem Shankar Mishra is a distinguished academician, researcher, and administrative leader in the field of Pharmaceutical Sciences. With over 15 years of professional experience, he has excelled in drug design, molecular docking, synthetic chemistry, and formulation development. Currently, he serves as Professor and Dean at Vidya University, Meerut, Uttar Pradesh. Dr. Mishra is known for his dynamic contributions to both academia and research, holding various prestigious positions such as Head of Central Instrumentation Facilities and PCI Inspector. He has published extensively, secured multiple national and international patents, and received significant research grants. His academic leadership extends into accreditations, regulatory affairs, and institutional development. He has received the International Academic Excellence Award 2022 and is widely recognized for his impactful research in anticancer drug discovery, Alzheimer’s therapy, and artificial intelligence applications in pharmacy.

Professional Profile

Education

Dr. Prem Shankar Mishra holds an illustrious academic background that reflects his deep commitment to pharmaceutical sciences. He earned his Ph.D. in Pharmacy, following a Master of Pharmacy (M. Pharm.) in Pharmaceutical Chemistry, and a Bachelor of Pharmacy (B. Pharm.). Complementing his scientific expertise, he also pursued a degree in Law (LLB), making him proficient in legal and regulatory frameworks relevant to the healthcare sector. His academic pursuits are grounded in rigorous research methodologies and an interdisciplinary approach, which integrates drug discovery, analytical chemistry, and legal knowledge. His educational journey empowered him with an extensive understanding of structural elucidation, spectroscopy (IR, NMR, HPLC, UV), and in-silico tools. This solid academic foundation has fueled his ability to contribute to academic excellence, institutional leadership, and cutting-edge scientific research.

Experience

With a professional journey spanning over 15 years, Dr. Mishra has demonstrated excellence in academic instruction, institutional leadership, and research development. He is currently the Dean of the School of Pharmacy at Vidya University, Meerut (since June 2025), and previously served as Professor and Head at Galgotias University (2017-2025). He began his academic career as an Assistant Professor at MIET, Meerut in 2010. His administrative roles include managing NBA and NAAC accreditation processes, leading Central Instrumentation Facilities, and serving as a PCI-approved Inspector. Dr. Mishra is also experienced in ISO certification protocols (ISO 9001:2015, ISO 17025:2017). His visionary leadership is evident in establishing research labs, fostering industry collaborations, and promoting a research-centric academic environment. His dynamic mentoring style and academic initiatives have empowered students and faculty alike, enriching the pharmaceutical education ecosystem.

Research Interests

Dr. Mishra’s research interests lie in drug design, heterocyclic synthesis, anticancer compounds, and pharmaceutical formulation development. His work spans synthetic and natural compounds, structural elucidation, and pharmacological evaluation. Notably, he has conducted extensive research in computer-aided drug design, de novo drug development, and in-vitro/in-vivo biological evaluations including anti-diabetic, anticancer, and antimicrobial assays. He has contributed significantly to the development of herbal formulations, nanoemulgels, biosensors, and mobile healthcare apps. His technical expertise also includes chromatographic method validation (HPLC, HPTLC, LC-MS), cytotoxicity assays (FACS, MTT, ROS generation), and molecular docking simulations. He has received multiple patents in India and abroad, especially in drug delivery and diagnostic device innovation. Dr. Mishra continues to push boundaries in translational pharmaceutical research that bridges laboratory discoveries with clinical applications.

Awards & Honors

Dr. Mishra has been recognized with numerous accolades that celebrate his academic and research excellence. Most notably, he received the International Academic Excellence Award 2022 at the Global Edu-Conclave. He is a recipient of competitive research grants, including Rs. 0.5 lakh each from the Council of Science and Technology (UP) and DRDO for organizing national scientific conferences. His credibility as an innovator is also evidenced by multiple national and international patent grants. Additionally, he holds leadership roles in institutional development, notably as a core team member for NAAC and NBA accreditation. His patents span biosensor technologies, nanoemulgels, anticancer formulations, and healthcare apps. These accomplishments underscore his dedication to innovation, policy, pedagogy, and scientific advancement, earning him a well-regarded status in the pharmaceutical academia and industry.

Top Noted Publications

Dr. Mishra has authored over 35 peer-reviewed publications in reputed international journals, covering diverse areas such as oncology, neurodegeneration, pharmacognosy, and pharmaceutical technology. Selected recent articles include:

1. Comprehensive Review on Alzheimer’s Disease: Natural Therapeutics, Gaps, and Challenges

  • Year: 2025

2. Natural Metabolites as Modulators of Sensing and Signaling Mechanisms: Unlocking Anti-Ovarian Cancer Potential

  • Year: 2025

3. AI-Assisted Immunology for Precision Cancer Medicine

  • Year: 2025

4. In-silico Screening and Synthesis of Benzo[c]Pyridazines Targeting N-Methyl D-Aspartate Glutamate Receptor for the Treatment of Seizures

  • Year: 2025

5. Novel 2-Pyridone Analogs with Anti-Cancer Activity: Synthesis, In silico, and In vitro Evaluation

  • Year: 2024

6. Role of Natural Secondary Metabolites as HIF-1 Inhibitors in Cancer Therapy

  • Year: 2024

Conclusion

Prof. Dr. Prem Shankar Mishra is an exceptionally qualified and highly deserving candidate for the Best Researcher Award. His prolific output in terms of peer-reviewed articles, awarded patents, leadership in pharmaceutical education, and recognized excellence through grants and awards reflect a sustained commitment to impactful research. With minor enhancements in global networking and translational research application, he could further amplify his scholarly legacy. Nonetheless, his current academic and research contributions already place him in the top tier of pharmaceutical science researchers.

Weiwei Fu | Molecular Biology | Best Researcher Award

Published on by Molecular Biologist

Dr. Weiwei Fu | Molecular Biology | Best Researcher Award 

Research assistant professor, at Peking University Third Hospital, China.

Dr. Fu Weiwei is an accomplished medical scientist specializing in gastroenterology and immunology. She currently serves as an Assistant Research Professor and Laboratory Director at the Gastroenterology Department, Peking University Third Hospital, where she leads research at the Beijing Key Laboratory. Dr. Fu earned her Ph.D. in Immunology from Peking University Health Science Center and has a strong foundation in traditional medicine, holding a Bachelor of Medicine from Shandong University. With more than a decade of experience in translational medical research, her work bridges cutting-edge immunological discoveries and practical clinical applications. Her focus lies in immune microenvironment dynamics, gastrointestinal tumor evolution, and the integration of traditional Chinese medicine for digestive disease therapies. She has delivered several high-profile international presentations and has published widely in leading scientific journals. Her contributions have significantly advanced the field of digestive immunology.

Professional Profile

Scopus

ORCID

🎓 Education

Dr. Fu’s academic journey began with a 5-year Bachelor of Medicine program at Shandong University of Traditional Chinese Medicine (2002–2007), where she laid a solid foundation in both conventional and traditional healthcare practices. Her early exposure to integrative medicine inspired a unique perspective on digestive health and immune response. Motivated by scientific rigor, she enrolled in the Combined Master’s and Ph.D. Program in Immunology (2008–2013) at Peking University Health Science Center, mentored by Prof. Wenling Han. This elite program sharpened her skills in molecular biology, immunopathology, and clinical translational research. Throughout her doctoral years, she focused on the host immune responses in cancer, particularly those related to gastric inflammation and tumorigenesis. This diverse academic training enables her to merge modern biomedical technologies with traditional insights, giving her an edge in the multidisciplinary field of digestive immunology.

🧪 Experience

Dr. Fu brings a wealth of research and clinical experience to her current position at the Gastroenterology Department, Peking University Third Hospital (2019–present), where she directs the Beijing Key Laboratory. As an Assistant Research Professor, she leads a team focusing on translational immunology in gastrointestinal diseases. Before this, she completed a prestigious postdoctoral fellowship (2013–2019) at the Tsinghua University Institute of Immunology under Prof. Chen Dong, an Academician of the Chinese Academy of Sciences. During this time, she worked on T-cell signaling, immune checkpoints, and the role of lymphoid cells in cancer. Her lab currently integrates clinical cohort data with multi-omics techniques to explore disease mechanisms. She is also instrumental in mentoring junior researchers and clinicians. Her work bridges laboratory immunology with bedside applications, ensuring scientific advancements are translated into improved diagnosis and therapy for patients.

🔬 Research Interests

Dr. Fu’s research centers on the immune microenvironment in gastrointestinal tumors and digestive tract diseases, such as gastric cancer and inflammatory bowel disease. She applies multi-omics technologies—including single-cell RNA sequencing, proteomics, and microbiome analysis—to decipher host-pathogen interactions and immune cell dynamics during disease evolution. A key aspect of her research is understanding how Helicobacter pylori infection initiates gastric lesions, tumor progression, and immune escape. She also investigates traditional Chinese medicine-based therapies, exploring their role in cancer prevention and immune modulation. Another focal point is early screening and biomarker discovery for precancerous lesions through clinical cohort studies. By integrating high-throughput data with clinical insights, her work aims to improve patient stratification and individualized treatments. Her interdisciplinary approach bridges immunology, oncology, and traditional medicine, placing her at the forefront of gastrointestinal research in China and beyond.

🏆 Awards

Dr. Fu’s scientific excellence has been consistently recognized. She won the Outstanding Paper Award at the 2023 Chinese Medical Association’s National Conference on Digestive Diseases (CGC 2023) for her oral presentation on immune profiling during colorectal cancer progression. Her continuous contributions to clinical immunology, translational oncology, and molecular diagnostics have earned her accolades from both national and international platforms. Her selection as an oral presenter at leading conferences—such as DDW 2024 in Washington, D.C., and UEGW 2023 in Copenhagen—speaks to her international recognition. She has also received patent grants for innovations in inflammation and cancer therapy, reflecting her drive for practical applications. As a dedicated researcher, educator, and innovator, Dr. Fu stands out as a top candidate for award nominations in the fields of biomedical research and clinical translational science.

📚 Top Noted Publications

Dr. Fu has authored and co-authored numerous impactful papers in top-tier journals (JCR Q1–Q3), often as first or corresponding author. Below are select publications with hyperlink.

2025

  1. Luteolin Improves Precancerous Gastric Mucosa by Binding STAT3
    International Journal of Biological Sciences (Q1, IF 8.1)
    📌 Co-Corresponding Author
    🧪 Original Research

  2. CMTM3 Regulates Colitis-Associated Cancer Progression
    Cellular and Molecular Gastroenterology and Hepatology (CMGH) (Q1, IF 7.1)
    📌 Co-Corresponding Author
    🧬 Original Research

  3. Cmtm4 Deficiency Exacerbates H. pylori-Induced Gastric Carcinogenesis
    Pathology International (Q2, IF 2.5)
    📌 Co-Corresponding Author
    🦠 Original Research

  4. The Host Immune Response Landscape in Gastric Cancer Development
    Clinical and Experimental Immunology (Q2, IF 3.4)
    📌 First Author
    🧫 Original Research

2024

  1. Neutrophil Heterogeneity in Hepatocellular Carcinoma and Tumor Immunity
    Cancer Medicine (Q2, IF 2.9)
    📌 Co-First Author
    🔬 Original Research

  2. Oxidative Balance in Diet and Sleep Patterns: A Metabolic Interaction
    Frontiers in Nutrition (Q2, IF 4.0)
    📌 Co-First Author
    🍽 Original Research

  3. CMTM4 Facilitates Gastric Cancer Metastasis via EMT Modulation
    Journal of Gastrointestinal Oncology (Q3, IF 2.0)
    📌 Co-First Author
    🧠 Original Research

  4. Cmtm4 Shapes Colitis Outcomes via Microbial Dysbiosis and Mucosal Immunity
    Journal of Genetics and Genomics (Q1, IF 6.6)
    📌 Co-Corresponding Author
    🧪 Original Research

  5. Serum Proteomics-Based Biomarkers of Precancerous Gastric Lesions
    Frontiers in Molecular Biosciences (Q2, IF 3.9)
    📌 Co-Corresponding Author
    🔍 Original Research

  6. Treg Subsets Orchestrate Tumor Microenvironment in Colorectal Cancer
    Frontiers in Immunology (Q1, IF 5.7)
    📌 Co-First & Corresponding Author
    🧫 Original Research

2023

  1. Helicobacter pylori and Inflammasome Activation in Gastric Pathogenesis (Review)
    Helicobacter (Q2, IF 4.3)
    📌 Co-Corresponding Author
    🧯 Review Article

2022

  • Lymphocyte Profile Alterations in Precancerous Gastric Lesions
    Journal of Leukocyte Biology (Q2, IF 5.5)
    📌 First Author
    🧬 Original Research

  • B7 Family Molecules and Immune Evasion in H. pylori Infection (Review)
    Helicobacter (Q2, IF 4.4)
    📌 Co-Corresponding Author
    🧫 Review Article

Conclusion

Dr. FU Weiwei demonstrates an exceptional and well-rounded profile as a medical researcher with significant contributions to immunology and gastroenterology, supported by prestigious academic training, a robust scientific publication record, impactful patents, and strong conference presence. These achievements, particularly in translational cancer immunology, make Dr. Fu highly suitable for the Best Researcher Award.

Foziljon Saitkulov | Biochemistry | Best Researcher Award

Published on by Molecular Biologist

Assist. Prof. Dr. Foziljon Saitkulov | Biochemistry | Best Researcher Award 

Assistant professor, at tashkent state agrarian university, Uzbekistan.

Dr. Saitkulov Foziljon Ergashevich, born on May 22, 1976, in Uzbekistan, is a distinguished organic chemist with over two decades of experience in academia and research. Currently serving as a PhD Associate Professor at Tashkent State Agrarian University, he has authored more than 120 scientific articles and theses, along with approximately 10 textbooks and training manuals. His expertise encompasses the synthesis of over 20 organic compounds and a patent in anthelmintic properties. Proficient in modern physical research instruments like ionometers, gas chromatographs, and infrared spectroscopes, Dr. Saitkulov is fluent in Russian, English, and Farsi. His dedication to science and education has significantly contributed to the field of organic chemistry in Uzbekistan.

Professional Profile

Scopus

ORCID​

🎓 Education 

Dr. Saitkulov’s academic journey began at Samarkand State University, where he earned his Bachelor’s degree in Chemistry in 2001. He further pursued a Master’s degree in Organic Chemistry at the same institution, graduating in 2006. His rigorous academic training laid a strong foundation for his future research endeavors. Throughout his studies, he developed a keen interest in heterocyclic compounds and their biological activities, which became the focal point of his subsequent research. His educational background has been instrumental in shaping his career as a researcher and educator in organic chemistry.​http://generis-publishing.com/

💼 Experience 

Dr. Saitkulov commenced his professional career as a teacher at Urgut District School No. 78 from 2001 to 2004. He then served as an assistant at Samarkand State University from 2006 to 2016, where he contributed to various research projects. From 2016 to 2020, he was a researcher at the Chemistry of Plant Substances Institute of the Academy of Sciences of the Republic of Uzbekistan. Since 2020, he has been affiliated with Tashkent State Agrarian University, progressing from assistant to senior teacher, and currently holds the position of PhD Associate Professor. His responsibilities have included teaching organic chemistry, supervising research, and developing educational materials.​

🔬 Research Interests 

Dr. Saitkulov’s research interests are centered around the synthesis and study of heterocyclic compounds, particularly quinazolin-4-one derivatives. He investigates their biological activities, including potential anthelmintic properties. His work involves exploring the biochemical effects of coordination compounds and their applications in agriculture and medicine. He is also interested in the development of environmentally friendly fertilizers and the analysis of plant-based compounds using advanced spectroscopic methods. His research contributes to the understanding of organic compounds’ roles in various biological processes.​ResearchGate+6http://generis-publishing.com/+6LIBROTERRA+6Premier Publishing

🏆 Awards

Dr. Saitkulov has been recognized for his significant contributions to organic chemistry through various awards and honors. His innovative research on quinazolin-4-one derivatives and their biological activities has garnered attention in scientific circles. He has received accolades for his publications and presentations at national and international conferences. His dedication to teaching and mentoring students has also been acknowledged by academic institutions. These awards reflect his commitment to advancing the field of organic chemistry and his impact on scientific research and education.​

📚Top Noted Publications 

Dr. Saitkulov has an extensive publication record, including over 120 scientific articles and theses. Notable publications include:​

1. Synthesis and Study of the Processes of Biochemical Action of the Coordination Compound of Cobalt(II) Nitrate Quinazolin-4-One with 3-Indolyl Acetic Acid in Amber Plants

  • Authors: [Add if applicable]

  • Year: 2022

  • Publisher: Premier Publishing

  • Summary: This work explores the synthesis of a cobalt(II) nitrate coordination compound with quinazolin-4-one and its biochemical action in Amber plants, focusing on potential growth stimulation via interaction with 3-indolyl acetic acid (a known auxin).

  • Indexing/Availability: ResearchGate [+1]

2. Synthesis of Stimulants Based on Heterocyclic Compounds Quinazolin-4-One

  • Authors: [Add if applicable]

  • Year: 2024

  • Publisher: LIBROTERRA

  • Summary: This study focuses on the design and chemical synthesis of stimulants using quinazolin-4-one as a heterocyclic scaffold, with possible applications in plant growth regulation or pharmaceutical precursors.

  • Indexing/Availability:

    • Zien Journals [+6]

    • ResearchGate [+6]

3. Investigation of Aromatic Properties of Xinazolin-4-One

  • Authors: [Add if applicable]

  • Year: 2024

  • Publisher: Premier Publishing

  • Summary: Focused on the structural and electronic aromatic characteristics of “Xinazolin-4-One” (presumably a structural analog or variation of quinazolin-4-one), this work includes computational or spectroscopic analysis to characterize aromatic stability.

  • Indexing/Availability: [Add source or DOI if available]

4. Synthesis of Some Quinazolin-4-One Series Heterocyclic Compounds and Their Biological Activities

  • Authors: [Add if applicable]

  • Year: 2024

  • Publisher: LIBROTERRA

  • Summary: This paper details the synthetic pathways of multiple quinazolin-4-one derivatives and evaluates their biological properties, potentially including antimicrobial or growth-promoting activities.

  • Also available via: Generis Publishing [+1]

Conclusion

Dr. Saitkulov Foziljon Ergashevich is a strong candidate for the Best Researcher Award, with substantial contributions to organic chemistry research and education over two decades. His track record of publication, compound synthesis, and educational resource development speaks to both academic rigor and real-world impact. With increased international exposure and research collaborations, he holds great potential to further enhance his scientific influence. Therefore, he is well-suited for recognition through this award, especially in categories emphasizing national leadership, innovation, and dedication to chemical sciences.